Novo Nordisk's Q1 in four words: Pills, pricing, payments and pressure

Mike Doustdar, Novo Nordisk CEO (Nichlas Pollier/Bloomberg via Getty Images) May 6, 2026 06:27 AM EDT Pharma No­vo Nordisk's first quar­ter in four words: Pills, pric­ing, pay­ments and pres­sure Elizabeth Cairns Senior biopharma journalist A mil­lion pa­tients with obe­si­ty are al­ready tak­ing No­vo Nordisk’s We­govy pill, CEO Mike Doust­dar said Wednes­day, de­spite the mar­ket en­try of … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER